JP2013144702A5 - - Google Patents

Download PDF

Info

Publication number: JP2013144702A5
Authority: JP; Japan
Prior art keywords: resin; ion exchange; exchange resin; molded article; transdermal administration
Prior art date: 2013-03-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

JP2013059477A

Other languages

English (en)

Japanese (ja)

Other versions

JP2013144702A (ja

Filing date

2013-03-22

Publication date

2014-06-19

2013-03-22 Application filed filed Critical

2013-07-25 Publication of JP2013144702A publication Critical patent/JP2013144702A/ja

2014-06-19 Publication of JP2013144702A5 publication Critical patent/JP2013144702A5/ja

Status Withdrawn legal-status Critical Current

Links

239000005557 antagonist Substances 0.000 claims description 6
239000011347 resin Substances 0.000 claims description 6
229920005989 resin Polymers 0.000 claims description 6
CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 claims description 3
125000000129 anionic group Chemical group 0.000 claims description 3
230000000937 inactivator Effects 0.000 claims description 3
239000002904 solvent Substances 0.000 claims description 3
229920000642 polymer Polymers 0.000 claims description 2
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims 7
239000003456 ion exchange resin Substances 0.000 claims 7
229920003303 ion-exchange polymer Polymers 0.000 claims 7
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
239000012790 adhesive layer Substances 0.000 claims 2
125000002091 cationic group Chemical group 0.000 claims 2
239000003795 chemical substances by application Substances 0.000 claims 2
125000000524 functional group Chemical group 0.000 claims 2
239000011159 matrix material Substances 0.000 claims 2
239000006211 transdermal dosage form Substances 0.000 claims 2
229920001651 Cyanoacrylate Polymers 0.000 claims 1
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
239000003729 cation exchange resin Substances 0.000 claims 1
NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 claims 1
125000005442 diisocyanate group Chemical group 0.000 claims 1
230000000415 inactivating effect Effects 0.000 claims 1
230000003993 interaction Effects 0.000 claims 1
238000005342 ion exchange Methods 0.000 claims 1
239000010410 layer Substances 0.000 claims 1
229940005483 opioid analgesics Drugs 0.000 claims 1
150000002978 peroxides Chemical class 0.000 claims 1
239000000377 silicon dioxide Substances 0.000 claims 1
239000012530 fluid Substances 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
239000003957 anion exchange resin Substances 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
210000001198 duodenum Anatomy 0.000 description 1
210000003238 esophagus Anatomy 0.000 description 1
239000012982 microporous membrane Substances 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1

JP2013059477A 2001-05-01 2013-03-22 濫用阻止式オピオイド内蔵経皮的システム Withdrawn JP2013144702A (ja)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US28787501P	2001-05-01	2001-05-01
US60/287,875		2001-05-01
US29253701P	2001-05-22	2001-05-22
US60/292,537		2001-05-22

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2002584836A Division JP5296284B2 (ja)	2001-05-01	2002-04-30	濫用阻止式オピオイド内蔵経皮的システム

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2014197710A Division JP2015042649A (ja)	2001-05-01	2014-09-29	濫用阻止式オピオイド内蔵経皮的システム

Publications (2)

Publication Number	Publication Date
JP2013144702A JP2013144702A (ja)	2013-07-25
JP2013144702A5 true JP2013144702A5 (2)	2014-06-19

Family

ID=26964697

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
JP2002584836A Expired - Fee Related JP5296284B2 (ja)	2001-05-01	2002-04-30	濫用阻止式オピオイド内蔵経皮的システム
JP2013059477A Withdrawn JP2013144702A (ja)	2001-05-01	2013-03-22	濫用阻止式オピオイド内蔵経皮的システム
JP2014197710A Pending JP2015042649A (ja)	2001-05-01	2014-09-29	濫用阻止式オピオイド内蔵経皮的システム

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
JP2002584836A Expired - Fee Related JP5296284B2 (ja)	2001-05-01	2002-04-30	濫用阻止式オピオイド内蔵経皮的システム

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP2014197710A Pending JP2015042649A (ja)	2001-05-01	2014-09-29	濫用阻止式オピオイド内蔵経皮的システム

Country Status (11)

Country	Link
US (2)	US20040241218A1 (2)
EP (3)	EP2062573B1 (2)
JP (3)	JP5296284B2 (2)
AT (2)	ATE533478T1 (2)
CY (2)	CY1108821T1 (2)
DE (1)	DE60230138D1 (2)
DK (3)	DK2062573T3 (2)
ES (3)	ES2318010T3 (2)
PT (3)	PT2062573E (2)
SI (3)	SI2062573T1 (2)
WO (1)	WO2002087482A1 (2)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5968547A (en)	1997-02-24	1999-10-19	Euro-Celtique, S.A.	Method of providing sustained analgesia with buprenorphine
AU2002339378A1 (en)	2001-05-22	2002-12-03	Euro-Celtique	Compartmentalized dosage form
DE10141650C1 (de)	2001-08-24	2002-11-28	Lohmann Therapie Syst Lts	Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
JP2005526839A (ja) *	2002-04-23	2005-09-08	アルザ・コーポレーシヨン	不正使用の可能性が低い経皮鎮痛薬システム
ES2283812T3 (es) *	2002-06-10	2007-11-01	Euro Celtique Sa	Sistemas de eliminacion de dispositivos de adminsitracion transdemica para prevenir el uso indebido de los agentes activos contenidos en los mismos.
US7815934B2 (en) *	2002-09-20	2010-10-19	Alpharma Pharmaceuticals, Llc	Sequestering subunit and related compositions and methods
DE10250088A1 (de) *	2002-10-25	2004-05-06	Grünenthal GmbH	Gegen Missbrauch gesicherte Darreichungsform
US8790689B2 (en) *	2003-04-30	2014-07-29	Purdue Pharma L.P.	Tamper resistant transdermal dosage form
US7182955B2 (en) *	2003-04-30	2007-02-27	3M Innovative Properties Company	Abuse-resistant transdermal dosage form
RS20050812A (sr) *	2003-04-30	2007-12-31	Purdue Pharma L.P.,	Transdermalni dozni oblik otporan na promene
US20040219195A1 (en) *	2003-04-30	2004-11-04	3M Innovative Properties Company	Abuse-resistant transdermal dosage form
DE602004011055T2 (de) *	2003-07-25	2008-12-18	Euro-Celtique S.A.	Präoperative behandlung von postoperativen schmerzen
CA2543610A1 (en) *	2003-10-30	2005-05-19	Alza Corporation	Transdermal analgesic systems having reduced abuse potential
US8535711B2 (en)	2004-01-23	2013-09-17	Teikoku Pharma Usa, Inc.	Medication disposal system
US7867511B2 (en)	2004-01-23	2011-01-11	Travanti Pharma Inc.	Abuse potential reduction in abusable substance dosage form
PT1718258E (pt) *	2004-02-23	2009-06-16	Euro Celtique Sa	Dispositivo de administração transdérmica de opióides com resistência ao abuso
WO2006023644A2 (en) *	2004-08-20	2006-03-02	3M Innovative Properties Company	Transdermal drug delivery device with translucent protective film
US7226619B1 (en)	2004-09-07	2007-06-05	Pharmorx Inc.	Material for controlling diversion of medications
AU2005284908B2 (en)	2004-09-13	2011-12-08	Morningside Venture Investments Limited	Biosynchronous transdermal drug delivery
US8252321B2 (en)	2004-09-13	2012-08-28	Chrono Therapeutics, Inc.	Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
SI1814531T1 (sl) *	2004-10-21	2010-10-29	Durect Corp	Transdermalni dostavni sistem
WO2006069008A1 (en) *	2004-12-22	2006-06-29	Vesta Medical, Llc	Compositions and devices for inactivation of pharmaceuticals to facilitate waste disposal, and methods thereof
US20060182819A1 (en) *	2005-02-17	2006-08-17	Ough Yon D	Soap scent patch and treatment for muscle spasm and pain
TW200640526A (en) *	2005-02-24	2006-12-01	Alza Corp	Transdermal electrotransport drug delivery systems with reduced abuse potential
EP1898891A2 (en) *	2005-05-13	2008-03-19	Alza Corporation	Multilayer drug delivery system with barrier against antagonist exposure
ATE478659T1 (de)	2005-05-13	2010-09-15	Alza Corp	Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss
US20070014839A1 (en) *	2005-07-18	2007-01-18	Stefan Bracht	Decomposer film for transdermal patches
US9056061B2 (en)	2005-09-23	2015-06-16	Alza Corporation	Transdermal nicotine salt delivery system
US8383149B2 (en)	2005-09-23	2013-02-26	Alza Corporation	High enhancer-loading polyacrylate formulation for transdermal applications
EP1968539A2 (en) *	2005-12-13	2008-09-17	Biodelivery Sciences International, Inc.	Abuse resistant transmucosal drug delivery device
DE102006025282A1 (de) *	2006-05-31	2007-12-20	Lts Lohmann Therapie-Systeme Ag	Selbstzerstörendes transdermales therapeutisches System
SI2719378T1 (sl)	2006-06-19	2016-11-30	Alpharma Pharmaceuticals Llc	Farmacevtski sestavki
US20080008747A1 (en) *	2006-07-07	2008-01-10	Royds Robert B	Transdermal patch
DK2054031T3 (en)	2006-07-21	2016-05-17	Biodelivery Sciences Int Inc	Transmucosal delivery devices with improved uptake
WO2008063301A2 (en) *	2006-10-11	2008-05-29	Alpharma, Inc.	Pharmaceutical compositions
US20080286348A1 (en) *	2007-05-16	2008-11-20	Todhunter John A	Secured transdermal delivery system
DE102007041557B4 (de) *	2007-08-29	2011-03-31	Lts Lohmann Therapie-Systeme Ag	Transdermales therapeutisches System enthaltend längliche Hohlkörper
US20090196890A1 (en) *	2007-12-17	2009-08-06	Alpharma Pharmaceuticals, Llc	Pharmaceutical compositions
US8623418B2 (en)	2007-12-17	2014-01-07	Alpharma Pharmaceuticals Llc	Pharmaceutical composition
JP2011515495A (ja) *	2008-03-26	2011-05-19	オールトランツインコーポレイティド	オピエートアゴニスト及びアゴニスト−アンタゴニストの乱用抑制経皮製剤
DE102008016804B4 (de) *	2008-04-02	2012-01-05	Lts Lohmann Therapie-Systeme Ag	Selbstzerstörendes transdermales therapeutisches System mit verbesserter Funktionalität und Wirksamkeit sowie seine Verwendung
JP2013523780A (ja) *	2010-04-02	2013-06-17	オールトランツインコーポレイティド	オピエートアゴニスト及びアゴニスト−アンタゴニストの乱用抑止性経皮製剤
WO2013006643A1 (en)	2011-07-06	2013-01-10	The Parkinson's Institute	Compositions and methods for treatment of symptoms in parkinson's disease patients
AU2012296346A1 (en)	2011-08-18	2014-04-03	Biodelivery Sciences International, Inc.	Abuse-resistant mucoadhesive devices for delivery of buprenorphine
WO2013049380A1 (en)	2011-09-30	2013-04-04	Teikoku Pharma Usa, Inc.	Transdermal patch disposal system
JP2014528276A (ja)	2011-09-30	2014-10-27	テイコクファーマユーエスエーインコーポレーテッド	一般用医薬品廃棄システム
US9901539B2 (en)	2011-12-21	2018-02-27	Biodelivery Sciences International, Inc.	Transmucosal drug delivery devices for use in chronic pain relief
WO2016049266A1 (en) *	2014-09-24	2016-03-31	Pain Therapeutics, Inc.	4:3 naltrexone: 5-methyl-2-furaldehyde cocrystal
US10010543B1 (en)	2014-12-23	2018-07-03	Barr Laboratories, Inc.	Transdermal dosage form
AU2016211330A1 (en)	2015-01-28	2017-08-03	Chrono Therapeutics Inc.	Drug delivery methods and systems
US10679516B2 (en)	2015-03-12	2020-06-09	Morningside Venture Investments Limited	Craving input and support system
WO2017147568A1 (en) *	2016-02-26	2017-08-31	Case Western Reserve University	Composite membranes for flow batteries
CA3049529A1 (en)	2017-01-06	2018-07-12	Chrono Therapeutics Inc.	Transdermal drug delivery devices and methods
US11389844B2 (en)	2018-03-20	2022-07-19	Verde Environmental Technologies, Inc.	Blister pack disposal system
US11596779B2 (en)	2018-05-29	2023-03-07	Morningside Venture Investments Limited	Drug delivery methods and systems
WO2020008366A1 (en) *	2018-07-02	2020-01-09	Clexio Biosciences Ltd.	Transdermal dosage form
WO2020009685A1 (en) *	2018-07-02	2020-01-09	John Tang	Transdermal dosage form
US20210346662A1 (en) *	2018-10-23	2021-11-11	Kindeva Drug Delivery L.P.	Tamper evident transdermal patch
US12397141B2 (en)	2018-11-16	2025-08-26	Morningside Venture Investments Limited	Thermally regulated transdermal drug delivery system
CN114401746A (zh) *	2019-08-12	2022-04-26	耶路撒冷希伯来大学伊森姆研究发展有限公司	包括鸦片拮抗剂组合的药学组合物及复合材料及其使用方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3643987A1 (de) *	1986-12-22	1988-06-23	Lohmann Therapie Syst Lts	Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
US5236714A (en)	1988-11-01	1993-08-17	Alza Corporation	Abusable substance dosage form having reduced abuse potential
US5028435A (en) *	1989-05-22	1991-07-02	Advanced Polymer Systems, Inc.	System and method for transdermal drug delivery
US5149538A (en) *	1991-06-14	1992-09-22	Warner-Lambert Company	Misuse-resistive transdermal opioid dosage form
US6096756A (en) *	1992-09-21	2000-08-01	Albert Einstein College Of Medicine Of Yeshiva University	Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
US5573778A (en) *	1995-03-17	1996-11-12	Adhesives Research, Inc.	Drug flux enhancer-tolerant pressure sensitive adhesive composition
WO1997004835A1 (de) *	1995-07-28	1997-02-13	Novartis Ag	Transdermales system
US7011843B2 (en) *	1997-10-01	2006-03-14	Lts Lohmann-Therapie Systeme Ag	Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system
CA2314896C (en) *	1997-12-22	2005-09-13	Euro-Celtique, S.A.	A method of preventing abuse of opioid dosage forms
US6554851B1 (en) *	1999-05-07	2003-04-29	Scimed Life Systems, Inc.	Methods of sealing an injection site
EP1424973B1 (en) *	2001-04-23	2010-03-03	Euro-Celtique S.A.	Disposal system for transdermal dosage form

2002
- 2002-04-30 DK DK08020810.1T patent/DK2062573T3/da active
- 2002-04-30 AT AT08020810T patent/ATE533478T1/de active
- 2002-04-30 WO PCT/US2002/014073 patent/WO2002087482A1/en not_active Ceased
- 2002-04-30 SI SI200230970T patent/SI2062573T1/sl unknown
- 2002-04-30 EP EP08020810A patent/EP2062573B1/en not_active Expired - Lifetime
- 2002-04-30 SI SI200231061T patent/SI2316439T1/sl unknown
- 2002-04-30 ES ES02731653T patent/ES2318010T3/es not_active Expired - Lifetime
- 2002-04-30 ES ES08020810T patent/ES2377672T3/es not_active Expired - Lifetime
- 2002-04-30 EP EP02731653A patent/EP1397095B1/en not_active Expired - Lifetime
- 2002-04-30 US US10/476,601 patent/US20040241218A1/en not_active Abandoned
- 2002-04-30 DK DK10009943.1T patent/DK2316439T3/en active
- 2002-04-30 SI SI200230785T patent/SI1397095T1/sl unknown
- 2002-04-30 PT PT08020810T patent/PT2062573E/pt unknown
- 2002-04-30 JP JP2002584836A patent/JP5296284B2/ja not_active Expired - Fee Related
- 2002-04-30 EP EP10009943.1A patent/EP2316439B1/en not_active Expired - Lifetime
- 2002-04-30 AT AT02731653T patent/ATE415952T1/de active
- 2002-04-30 ES ES10009943.1T patent/ES2546828T3/es not_active Expired - Lifetime
- 2002-04-30 PT PT100099431T patent/PT2316439E/pt unknown
- 2002-04-30 DK DK02731653T patent/DK1397095T3/da active
- 2002-04-30 PT PT02731653T patent/PT1397095E/pt unknown
- 2002-04-30 DE DE60230138T patent/DE60230138D1/de not_active Expired - Lifetime
2009
- 2009-02-26 CY CY20091100224T patent/CY1108821T1/el unknown
2012
- 2012-02-01 CY CY20121100110T patent/CY1112271T1/el unknown
2013
- 2013-03-22 JP JP2013059477A patent/JP2013144702A/ja not_active Withdrawn
2014
- 2014-01-21 US US14/159,894 patent/US20140199383A1/en not_active Abandoned
- 2014-09-29 JP JP2014197710A patent/JP2015042649A/ja active Pending

Publication	Publication Date	Title
JP2013144702A5 (2)	2014-06-19
JP2012525474A5 (2)	2013-05-30
BRPI0719006A2 (pt)	2013-12-17	Sistemas terapêuticos transdérmicos com alto índice de utilização de substância ativa e exatidão de dosagem
NZ589542A (en)	2012-10-26	Transdermal drug delivery system comprising an active agent in amorphous form and polyvinylpyrrolidone
JP2014025006A5 (2)	2015-12-24
JP2013517960A5 (2)	2014-03-06
JP2007536568A5 (2)	2008-03-27
JP2007264092A5 (2)	2007-11-22
WO2006081518A3 (en)	2006-11-23	Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents
JP2005502430A5 (2)	2006-01-05
WO2006128471A3 (en)	2007-02-08	A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids
WO2010070483A3 (en)	2010-09-02	Substrates providing multiple releases of active agents
JP2018507926A5 (2)	2019-01-31
JP2016196566A5 (2)	2017-04-06
MX2019001104A (es)	2019-10-02	Sistemas de suministro transdermico de memantina.
JP2017204003A5 (2)	2020-02-27
JP2016190997A5 (2)	2016-12-22
HK1216503A1 (zh)	2016-11-18	用於經皮傳遞安非他命的組合物及方法
JP2013163782A5 (2)	2015-09-24
JP2018529803A5 (2)	2019-09-26
JP2010536898A5 (2)	2011-07-21
JP2011154700A (ja)	2011-08-11	タッチパネル用部材およびタッチパネル
ES2777208T3 (es)	2020-08-04	Cuerpo de soporte para parche transdérmico o preparación transdérmica, y parche transdérmico y preparación transdérmica que usan el mismo
EP1784169B1 (en)	2012-03-21	Polymeric adhesive matrix with salified carboxylic groups for transdermal use
EP1928431B8 (en)	2009-04-08	Controlled release pharmaceutical composition containing carvedilol